Approvals/TGA/MEZAVANT mesalazine 1.2 g gastro-resistant, prolonged release tablet blister pack

Approved

STANDARD

MEZAVANT mesalazine 1.2 g gastro-resistant, prolonged release tablet blister pack

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 833ab1f8e7d0b241
Product Name: MEZAVANT mesalazine 1.2 g gastro-resistant, prolonged release tablet blister pack
Artg Id: 155172
Artg Name: MEZAVANT mesalazine 1.2 g gastro-resistant, prolonged release tablet blister pack
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2009-09-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/91f83951bfb9ff9700a9f7ffb38bce3d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4f8df3e0ece811feda13a7ee48f5a358.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

833ab1f8e7d0b241

Type

Standard